NDA 018826 · Hospira
Dopamine Hydrochloride In Dextrose 5% In Plastic Container
Dopamine Hydrochloride · Injection
Last checked: Nov 20, 2026Latest source record: Jun 4, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1983
Sep 30, 1983
Approved uses
1
Original approval plus efficacy supplements
Registered trials
586
103 Phase 3, 70 recruiting
FAERS reports
1
1 serious, 1 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 21, 2026.
Dopamine Hydrochloride in Dextrose Injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output. Dopamine HCl in Dextrose Injection is a catecholamine indicated to improve hemodynamic status in patients in shock. ( 1 )
Mechanism: Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine elicits its pharmacological action by activating dopamine D1 and D2 receptors, beta-1 receptors and alpha-1 receptors. The activation of different receptors leading to its effects are dependent on dopamine dose.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Sep 30, 1983 Original approval · Type 5 - New Formulation or New Manufacturer
3 products under this application
- DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER · DOPAMINE HYDROCHLORIDE 160MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
- DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER · DOPAMINE HYDROCHLORIDE 320MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
- DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER · DOPAMINE HYDROCHLORIDE 80MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Dopamine" as an intervention, any sponsor and status, largest first.
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Diagnosis of PheochromocytomaRecruiting
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
NCT00004847 · 3,000 participants (planned) · Start Mar 22, 2000 · Primary completion Nov 30, 2048
Drug: ([18F]-DOPA); ([18F]-6F-DA) · For: Pheochromocytoma; Endocrine Disease; Endocrine Diseases
Sites: Bethesda, Maryland
- Target Hemodynamics and Brain Injury During General Anesthesia in the ElderlyPivotal-lookingSuspended
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoAcademic, hospital or other
NCT02428062 · 1,812 participants (planned) · Start Oct 2014 · Primary completion Dec 2018
Drug: Phenylephrine; Intravenous fluids and 4 more · For: Post-operative Cognitive Dysfunction
Sites: Milan, Italy
- Dopamine and Norepinephrine in Shock PatientsPivotal-lookingCompleted
Sepsis Occurrence in Acutely Ill PatientsAcademic, hospital or other
NCT00314704 · 1,679 participants · Start Dec 2003 · Primary completion Oct 2007
Drug: dopamine versus norepinephrine · For: Shock
Sites: Vienna, Austria; Brussels, Belgium; Charleroi, Belgium · 8 sites in all
- Platform Adaptive Embedded Trial for Acute Respiratory Distress SyndromePivotal-lookingStatus unknown
Second Affiliated Hospital, Zhejiang University, School of MedicineAcademic, hospital or other
NCT05658692 · 1,000 participants (planned) · Start Oct 1, 2022 · Primary completion Oct 2023
Drug: glucocorticoid therapy; Thymosin Alpha and 5 more · For: Acute Respiratory Distress Syndrome
Sites: Beijing, China; Chengdu, China; Guangdong, China · 11 sites in all
Ken Marek, MDAcademic, hospital or other
NCT01141023 · 952 participants · Start Jun 2010 · Primary completion Jun 30, 2020
Drug: DaTscan · For: Parkinson Disease
Sites: Birmingham, Alabama; Sun City, Arizona; La Jolla, California · 34 sites in all
- PRolaCT - Three Prolactinoma RCTsPivotal-lookingStatus unknown
Leiden University Medical CenterAcademic, hospital or other
NCT04107480 · 880 participants (planned) · Start Jun 21, 2019 · Primary completion Mar 31, 2024
Drug: Dopamine Agonists · For: Prolactinoma; Prolactin-Producing Pituitary Tumor
Sites: Amsterdam-Zuidoost, Netherlands; Delft, Netherlands; Leiden, Netherlands
- Open-Label Safety Study of AXS-05 in Subjects With DepressionPivotal-lookingCompleted
Axsome Therapeutics, Inc.Industry
NCT04039022 · 876 participants · Start Jul 8, 2019 · Primary completion Oct 23, 2020
Drug: AXS-05 (dextromethorphan and bupropion) oral tablets · For: Major Depressive Disorder; Treatment Resistant Depression; Depression
Sites: Phoenix, Arizona; Little Rock, Arkansas; Bellflower, California · 51 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- blood loss anaemia neonatal1
- blood pressure decreased1
- pneumonia1
- sepsis1
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2013 | 1 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Current · updated Nov 9, 2026
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24). Other
Current · updated Nov 9, 2026
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12).
Current · updated Nov 9, 2026
Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12).
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta-Analysis.
Feber L, Peter NL, Chiocchia V, et al. · JAMA Psychiatry 2025 · Systematic Review, Network Meta-Analysis
- Comparison of dopamine and norepinephrine in the treatment of shock.
De Backer D, Biston P, Devriendt J, et al. · N Engl J Med 2010 · Comparative Study, Multicenter Study
- Cortisol decreases and serotonin and dopamine increase following massage therapy.
Field T, Hernandez-Reif M, Diego M, et al. · Int J Neurosci 2005 · Clinical Trial, Randomized Controlled Trial
- Comparative efficacy and tolerability of antidopaminergic and muscarinic antipsychotics for acute schizophrenia: a network meta-analysis of randomised controlled trials indexed in international English and Chinese databases.
Schneider-Thoma J, Zhu Y, Qin M, et al. · Lancet 2026 · Comparative Study, Network Meta-Analysis
- THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L, Wang P, Li C, et al. · Shock 2023 · Systematic Review, Network Meta-Analysis
- Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
Sacheli MA, Neva JL, Lakhani B, et al. · Mov Disord 2019 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Sponsor: Pfizer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.